ArticleBMC pediatrics2026
Lipoblastoma of the head and neck in children: a single-institution study.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveLipoblastoma is a rare benign tumour, with a higher recurrence rate in the head and neck region owing to complex anatomy. The study summarizes the clinical features, surgical risks, and complications of paediatric lipoblastoma in various anatomical domains of the head and neck, aiming to improve diagnosis and management.
methodsA retrospective review was conducted on children who were treated for lipoblastoma of the head and neck between 2016 and 2023. Data assessed included location, demographics, clinical presentation, imaging, treatment, complications, recurrence, and follow-up.
resultsA total of 32 patients with lipoblastoma were retrospectively analyzed. These lipoblastomas located in the face (n = 2, 6.3%), nuchal region (n = 3, 9.4%), anterior neck (n = 6, 18.8%), lateral neck (n = 1, 3.1%), parapharyngeal region (n = 6, 18.8%), cervicomediastinal region (n = 4, 12.5%), and cervicoscapular-axillary region (n = 10, 31.3%). Complete resection was achieved in twenty-four cases. Residual lesions were confirmed in eight patients (25.0%). During a mean follow-up of 64.2 months, residual lesions regressed in two patients, remained stable in four, and progressed in two parapharyngeal cases that required secondary surgery via a transcervical approach. No recurrence was observed after complete resection.
conclusionA location-based approach aids in understanding surgical risk and prognosis in pediatric head and neck lipoblastoma. Given the benign nature and favorable outcomes, maximal safe resection with preservation of critical neurovascular structures is recommended. Complete excision may be technically challenging in deep head and neck spaces, and careful surgical planning is essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.